GREY:IMVIF - Post by User
Comment by
qwerty22on Feb 04, 2021 5:14pm
![](https://assets.stockhouse.com/kentico-cms/0342-00/images/Sprite.svg#id_Post_Views_Icon)
256 Views
Post# 32479342
RE:RE:RE:RE:Anyone have any idea what's up?
RE:RE:RE:RE:Anyone have any idea what's up?I don't think they ever promised a Merck deal. They promised progress on the regulatory front moving toward a registrational trial that would be for dpx+keytruda combo. That inevitably brings Merck along for the ride but I don't know it necessarily needs to changes the present arrangement too much. It could do though.
Having said that I hope ur right, a deeper partnership with Merck would be a dream come true. It certainly starting to feel like make or break time (again).
QM45 wrote: I suspect the deal between IMV and Merck on DLBCL reg. trial is being inked out or already has been and the word has leaked out as it usually does.
Considering that the volume is mostly coming from US and TSX has been catatonic, that seems like the most likely scenario in play.
Although Ors and Co have made many promises in the past, I do think they are pretty focused on moving oncology forward and the end of Q1 Merck deal should happen as promissed.
The large buyer at 100K+ lots over the last month or so has been painting the chart and has done a fabulous job. They created a very pretty cup and handle break out formation from a nice two month long basing pattern. Combined with lovely divergence on the last low in Stoch and MACD, most amateur technical analysts should be salivating...
In any case, it's up to Ors and Co. to mess it up as it sure looks very promising at the moment :)